天辰生物医药递表港交所 独家保荐人为国金证券香港

Group 1 - The core viewpoint of the article is that Tianchen Biopharmaceuticals (Suzhou) Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange, with Guotai Junan Securities (Hong Kong) as the exclusive sponsor [1] - Tianchen Biopharmaceuticals is focused on the development of innovative drugs, specifically targeting allergic and autoimmune diseases [1] - The company has established a comprehensive pipeline of biopharmaceutical products aimed at various medical fields, including otolaryngology, dermatology, respiratory medicine, hematology, nephrology, and other autoimmune diseases [1]